These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29299988)

  • 1. An Overview of Discovery of Thiazole Containing Heterocycles as Potent GSK-3β Inhibitors.
    Sharma D; Malhotra A; Bansal R
    Curr Drug Discov Technol; 2018; 15(3):229-235. PubMed ID: 29299988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors.
    Hulcová D; Breiterová K; Siatka T; Klímová K; Davani L; Šafratová M; Hošťálková A; De Simone A; Andrisano V; Cahlíková L
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29561817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer.
    Walz A; Ugolkov A; Chandra S; Kozikowski A; Carneiro BA; O'Halloran TV; Giles FJ; Billadeau DD; Mazar AP
    Clin Cancer Res; 2017 Apr; 23(8):1891-1897. PubMed ID: 28053024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review.
    Xu M; Wang SL; Zhu L; Wu PY; Dai WB; Rakesh KP
    Eur J Med Chem; 2019 Feb; 164():448-470. PubMed ID: 30616053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new GSK-3β inhibitors through structure-based virtual screening.
    Dou X; Jiang L; Wang Y; Jin H; Liu Z; Zhang L
    Bioorg Med Chem Lett; 2018 Jan; 28(2):160-166. PubMed ID: 29208522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine Fungi as Producers of Benzocoumarins, a New Class of Inhibitors of Glycogen-Synthase-Kinase 3β.
    Wiese J; Imhoff JF; Gulder TA; Labes A; Schmaljohann R
    Mar Drugs; 2016 Oct; 14(11):. PubMed ID: 27801816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).
    Gao Y; Zhang P; Cui A; Ye DY; Xiang M; Chu Y
    Bioorg Med Chem; 2018 Nov; 26(20):5479-5493. PubMed ID: 30293796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.
    Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
    Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
    Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
    J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycogen synthase kinase 3beta ameliorates triptolide-induced acute cardiac injury by desensitizing mitochondrial permeability transition.
    Wang W; Yang Y; Xiong Z; Kong J; Fu X; Shen F; Huang Z
    Toxicol Appl Pharmacol; 2016 Dec; 313():195-203. PubMed ID: 27751939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors.
    De Simone A; Fiori J; Naldi M; D'Urzo A; Tumiatti V; Milelli A; Andrisano V
    J Pharm Biomed Anal; 2017 Sep; 144():159-166. PubMed ID: 28268049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity.
    Wei J; Wang J; Zhang J; Yang J; Wang G; Wang Y
    Eur J Med Chem; 2022 Jun; 236():114301. PubMed ID: 35390715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
    Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
    J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.
    Chen S; Sun KX; Feng MX; Sang XB; Liu BL; Zhao Y
    Drug Des Devel Ther; 2016; 10():1225-32. PubMed ID: 27051274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer.
    Gao Y; Ye DY; Zhou WC; Chu Y
    Eur J Med Chem; 2017 Jul; 135():370-381. PubMed ID: 28460311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine 9 and tyrosine 216 phosphorylation of GSK-3β differentially regulates autophagy in acquired cadmium resistance.
    Park CH; Lee BH; Ahn SG; Yoon JH; Oh SH
    Toxicol Sci; 2013 Oct; 135(2):380-9. PubMed ID: 23897984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.